Deep Science Ventures
Deep Science Ventures is a London-based venture creator that builds deeptech companies across Agriculture, Climate, Computation, Pharma, and Education using an 8-step methodology anchored by its proprietary Outcomes Graph knowledge base and the Venture Science Doctorate programme.
- Company typePrivate
- Founded2016
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Deep Science Ventures does
Deep Science Ventures (DSV) is a London-based venture creator founded in 2016 that builds deeptech companies by combining available scientific knowledge with founder-type scientists across five sectors: Agriculture, Climate, Computation, Pharma, and Education. Its core platform is the Outcomes Graph, a collaborative hyperlinked knowledge base that characterises outcomes, constraints, and solutions using dynamic logical operators, enabling the firm to work backwards from desired societal outcomes rather than forwards from existing ideas. DSV executes an 8-step venture creation methodology from sector identification through pre-incorporation de-risking to spin-out, and operates the Venture Science Doctorate, a sector-agnostic PhD programme providing 14 venture scientists access to 40+ global academic and industry lab partners.
The firm has launched 58 portfolio companies spanning direct air capture (Yama, Parallel Carbon), green hydrogen (Supercritical), critical metals extraction (Thunderstone), electrolytic iron/nickel (Ironic Metals), accelerated computing (Xonai), antibody discovery (Antiverse), cancer therapeutics (Enedra Therapeutics, Kindling Bio, CureAge Therapeutics), automated cell manufacturing (Mytos), and surgical optimisation (Scalpel). Portfolio-company funding has exceeded $240M from investors including Breakthrough Energy Ventures, Lowercarbon Capital, Sequoia, Sam Altman, and Patrick Collison, with portfolio valuation of $700M+. DSV operates offices in London, Tokyo, and Boston, and maintains funded corporate and philanthropic partnerships with AbbVie, Cancer Research UK, GSK, Anglo American, Coca-Cola, ARIA, Parkinson's UK, the Children's Tumor Foundation, the Cystic Fibrosis Foundation, CGIAR, SPRIND, Renaissance Philanthropy, and others.
DSV generates returns primarily through equity stakes retained when portfolio companies spin out, supplemented by funded partnership arrangements with corporate and philanthropic sponsors. The company does not sell products or services in the conventional sense; revenue derives from venture equity economics and partnership-funded programme management rather than disclosed pricing or product sales. Customer relationships are tripartite (founders, corporate partners, investors) and the firm does not publicly disclose revenue, pricing, or detailed financial terms.
Deep Science Ventures firmographics
Firmographics- Name
- Deep Science Ventures
- Legal name
- Deep Science Ventures Limited
- Website
- https://deepscienceventures.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Deep Science Ventures is a London-based venture creator that builds deeptech companies across Agriculture, Climate, Computation, Pharma, and Education using an 8-step methodology anchored by its proprietary Outcomes Graph knowledge base and the Venture Science Doctorate programme.
- Ownership category
- akta.pro rank
Deep Science Ventures industry classification
Industry- Product category
- Venture Creation Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Computer Systems Design Services (541512)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Computer Integrated Systems Design (7373), Services-Computer Programming Services (7371)
- akta.pro primary industry
- Corporate Deep Tech / R&D Commercialization CVC (FSANAHAL)
- akta.pro secondary industries
- Joint Venture CVC / Consortium Funds (Multi-corporate) (FSANAHAE), AAV Vector Gene Therapy Developers (HLAAACAA), Climate Finance, Carbon Markets & MRV Systems (BPADALAB)
Keywords
Where Deep Science Ventures is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Deep Science Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Equity stakes in portfolio companies: DSV invests alongside other industry-leading investors when portfolio companies spin out from DSV. The company creates ventures and retains equity, generating returns through exits of portfolio companies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Deep Science Ventures product offering
Product offeringCore offering
DSV is a venture creator that combines available scientific knowledge with founder-type scientists to build high-impact deeptech ventures across Agriculture, Computation, Climate, Pharma, and Education. It applies a proprietary 8-step venture creation methodology anchored by the Outcomes Graph knowledge base to scope sectors, identify founders, de-risk opportunities pre-incorporation, and spin out companies. DSV also runs the Venture Science Doctorate programme and maintains a global network of 40+ academic and industrial laboratory partners to support venture creation.
Product overview
Deep Science Ventures (DSV) is a venture creator that builds deeptech companies in four sectors: Agriculture, Climate, Computation, and Pharmaceuticals. Rather than a single software product, DSV operates through a venture creation methodology anchored by the Outcomes Graph—a proprietary knowledge coordination system—and the Venture Science Doctorate—an entrepreneurship-focused PhD programme. Their portfolio includes 58 launched companies across sectors including regenerative agriculture ventures (Rhizocore, PES, Hot Green Solutions), climate ventures (Yama, Parallel Carbon, Supercritical, Ironic Metals, Thunderstone, Mark1, Malachite), pharma ventures (Enedra Therapeutics, Kindling Bio, Neobe Therapeutics, CureAge Therapeutics, Antiverse, Mytos, Deliver Biosciences), and computation ventures (Dunia, Flow Engineering, Xonai, ConcR, Scalpel). The company supports these ventures through a global network of 40+ academic lab partners and has raised $240M+ from investors including Breakthrough Energy Ventures, Lowercarbon Capital, and Sequoia.
Differentiator
Problem solved
Functional benefit
Products and services
- Venture Science Doctorate Sector-agnostic, venture-focused doctoral training programme that provides full autonomy to select research topics, access to 40+ global laboratories, and an all-expenses-paid package covering tuition, stipends, travel, and research consumables. Aimed at founder-type scientists building deeptech ventures during their doctoral studies.
- Venture Creation Services End-to-end venture creation service in which DSV identifies sectors via the Outcomes Graph, scopes opportunities, recruits founder-scientists, applies first-principles analysis, builds teams, de-risks riskiest assumptions pre-incorporation, and spins out companies with investment from DSV and co-investors. Targeted at industry partners, founders and investors.
- Global Lab Network A decentralised network of 40+ leading academic and industrial laboratory partners across the UK, EU and US, including The National Physical Laboratory, GlaxoSmithKline, King's College London, Max Planck Institutes, The Helmholtz Association, EMBL, German Cancer Research Center, CGIAR, and others, providing venture scientists with fluid access to facilities across multiple countries.
Companies that use Deep Science Ventures
Customer profileNamed customers17 records
Segments3 records
Ideal customer profiles3 records
Deep Science Ventures technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature2 records
Deep Science Ventures partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered core and minor.
- Medicines Discovery CatapultcoreCollaboration to address challenge of delivering medicines across the blood-brain barrier into the central nervous system. First phase involves review of current medicines landscape to identify systemic gaps in brain-entry technologies. Long-term aim to spin out novel approaches into new ventures with pre-seed funding.
- Renaissance PhilanthropycoreLaunched venture creation initiative under Climate Emergencies Resilience Lab (CERL) to develop field-ready crop resilience technologies. Addresses funding gap where traditional VC cannot support long-cycle, complex R&D required for climate solutions. Partners estimate climate-driven agricultural collapse could cost $1.8 trillion and 887 million years of healthy life by 2050.
- Future Fit AsiaminorDSV partners with Future Fit Asia (formerly Future Food Asia) to deliver Grantham Foundation Detox Awards providing $90,000 in non-dilutive funding for solutions addressing chemical toxicity in human and natural systems.
- Global Impact CoalitionminorLeading platform enabling sustainability in the chemical sector partnered with DSV to accelerate sustainable innovation by uniting chemical industry expertise with DSV's venture creation model.
- General InceptionminorPartnership combines DSV's first-principles methodology and AI tools with General Inception's expertise in advancing early-stage innovations to drive scientific discovery and venture creation in fibrosis-focused therapeutics.
- RMI and Third DerivativeminorJoint launch of Mark1 to revolutionise project development for critical, capital-intensive climate tech startups. Addresses decarbonizing industrial heat in India and Southeast Asia where rapid urbanization drives demand for low-carbon heating solutions.
- The National Physical LaboratorycoreUK's national measurement laboratory partnered with DSV's Venture Science Doctorate programme, providing access to high-precision measurement facilities for venture scientists.
- GlaxoSmithKlinecorePharmaceutical partner in Venture Science Doctorate lab network, providing access to industry research facilities and expertise.
- King's College LondoncoreAcademic partner in Venture Science Doctorate network, providing world-class research facilities including access to real patient samples for clinical research.
- Max Planck InstitutescoreGerman research network partner in Venture Science Doctorate programme, providing access to world-class German research facilities.
- The Helmholtz AssociationcoreEurope's largest research asset partnered with Venture Science Doctorate, providing access to extensive German research infrastructure.
- Health & Life Science Alliance Heidelberg MannheimcoreIncludes European Molecular Biology Laboratory (EMBL) and German Cancer Research Center (DKFZ), providing comprehensive life science research facilities.
- CGIAR (Alliance of Bioversity International and CIAT)corePartnership extends research, supervision and talent attraction capabilities of DSV's Venture Science Doctorate programme in agricultural sciences.
- Parkinson's UKminorAlliance to forge new pathways in Parkinson's therapeutics, applying DSV's venture creation approach to neurological disease treatment.
- Children's Tumor FoundationminorPartnership to uncover approaches within Neurofibromatosis, using DSV's methodology to identify novel therapeutic opportunities.
- Cystic Fibrosis FoundationminorPartnership to uncover approaches within Cystic Fibrosis using DSV's venture creation methodology to identify novel therapeutic opportunities.
- AbbViecoreGlobal pharmaceutical partnership to create ventures targeting immune-mediated inflammatory diseases using DSV's venture creation methodology.
- Cancer Research UKcoreExpanded partnership to develop curative therapies for cancer patients. DSV uses venture creation methodology to uncover novel therapeutics approaches in oncology.
- CRUSA FoundationminorCosta Rican foundation partnered with DSV for Tropical Agriculture & Bioeconomy Initiative, creating companies focused on regenerative agriculture in Costa Rica.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Deep Science Ventures competitors and assessment
Company assessmentDirect peers
- Entrepreneur First: Global venture builder that identifies and recruits technical founders (often scientists) to build deep tech companies from inception, retaining equity. EF operates the same founder-finding, first-principles venture studio model as DSV across multiple geographies, making it the closest head-to-head peer.
- Flagship Pioneering: US-based venture creator that originates and builds biotech and life sciences companies from scratch, retaining significant equity through a defined creation methodology. Comparable to DSV's Pharma sector in process and economics, and the most successful example of a science-first venture studio.
- Antler: Global venture builder that recruits founders in cohorts and supports them through company creation, with significant portfolio breadth across geographies. Antler's founder-finding, cohort-based model parallels DSV's Venture Science Doctorate and sector-led venture creation approach.
- SOSV: Multi-stage venture firm operating vertical accelerators (HAX for hardware, IndieBio for biotech, dlab for computational biology) that creates and invests early in deep tech startups. Overlaps directly with DSV's portfolio verticals — particularly biotech, hardware/climate, and computation.
- Creative Destruction Lab: Science-based venture builder with objective-driven cohorts that help founders translate research into high-impact companies. CDL's methodology of working from scientific objectives to commercial outcomes mirrors DSV's Outcomes Graph approach.
- Betaworks: New York-based venture studio that builds and invests in early-stage technology companies from inception. While less deep-tech focused than DSV, Betaworks shares the studio-style venture creation and equity retention model with comparable portfolio economics.
Emerging players
- Science Creates Ventures: UK-based deep tech VC that co-invested with DSV in Houdini Bio's pre-Seed. Operates in the same UK deep tech ecosystem with similar sector overlap (biotech, climate) and represents an adjacent funding partner / partial peer in venture creation territory.
Regional players
- Stride.VC: UK-based early-stage venture capital firm that partners with founders at company creation. Shares DSV's UK base and founder-led investing ethos but with a more generalist portfolio rather than DSV's deep tech sector specialism.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Deep Science Ventures social profiles
Digital presenceDeep Science Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Deep Science Ventures leadership team
Management profileNumber of profiles
Profiles14 records
Deep Science Ventures funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Deep Science Ventures M&A and investment
M&A and investmentM&A
Investments19 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Deep Science Ventures
What does Deep Science Ventures do?
DSV is a venture creator that combines available scientific knowledge with founder-type scientists to build high-impact deeptech ventures across Agriculture, Computation, Climate, Pharma, and Education. It applies a proprietary 8-step venture creation methodology anchored by the Outcomes Graph knowledge base to scope sectors, identify founders, de-risk opportunities pre-incorporation, and spin out companies. DSV also runs the Venture Science Doctorate programme and maintains a global network of 40+ academic and industrial laboratory partners to support venture creation.
Is Deep Science Ventures a public or private company?
Deep Science Ventures is a private company. It is classified as venture growth investor backed and is currently operating.
When was Deep Science Ventures founded?
Deep Science Ventures was founded in 2016. It employs 11 to 50 people.
Where is Deep Science Ventures based?
Deep Science Ventures is headquartered in London, United Kingdom, in the Europe region.
How does Deep Science Ventures make money?
One revenue line is on record: equity stakes in portfolio companies.
Who are Deep Science Ventures's main competitors?
Direct peers on record are Entrepreneur First, Flagship Pioneering, Antler, SOSV, Creative Destruction Lab and Betaworks. Science Creates Ventures is listed as an emerging player. Stride.VC is listed as a regional player.
Does Deep Science Ventures have an API?
No public API is recorded for Deep Science Ventures.
What industry is Deep Science Ventures in?
Deep Science Ventures's product category is Venture Creation Services. Its primary akta.pro industry code is FSANAHAL, Corporate Deep Tech / R&D Commercialization CVC, with a secondary code of FSANAHAE, Joint Venture CVC / Consortium Funds (Multi-corporate). Its NAICS code is 54171 and its SIC code is 8731.